Search

Your search keyword '"Andrews, Jane M."' showing total 1,052 results

Search Constraints

Start Over You searched for: Author "Andrews, Jane M." Remove constraint Author: "Andrews, Jane M."
1,052 results on '"Andrews, Jane M."'

Search Results

155. Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: An observational cohort prospective study

157. 'It doesn't do any harm, but patients feel better': a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease

158. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

159. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

160. Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease.

161. Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease.

162. Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure.

163. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes.

166. Su1909 - Crohn's Disease Patients with at Least 1 Nod2 Mutations and Who Smoke Regularly are Four Times as Likely to Need two or more Resections

167. Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis

168. Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)

170. Mo1879 - Vedolizumab(VDZ) Real World Outcomes in Ulcerative Colitis (UC)

172. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

175. Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease

176. Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

183. Serologic antibodies in relation to outcome in postoperative Crohn's disease

184. Short Duration, Low Intensity, Pooled Fecal Microbiota Transplantation Induces Remission in Patients with Mild-Moderately Active Ulcerative Colitis: A Randomised Controlled Trial

187. Adalimumab and Infliximab Levels in Neonates (ERA Study)

188. Adalimumab and Infliximab clearance in neonates (ERA study)

189. Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

190. Referrals to a tertiary hospital: a window into clinical management issues in functional gastrointestinal disorders

191. Nutrient-induced spatial patterning of human duodenal motor function

192. Pregnancy outcome and counselling of anti-TNF-α treated IBD women

194. Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice

195. 'I'm a sick person, not a bad person': patient experiences of treatments for alcohol use disorders

196. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

197. Cognitive behavioral therapy for IBD

198. Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms

199. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

200. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes : a genetic association study

Catalog

Books, media, physical & digital resources